期刊
JOURNAL OF EXPERIMENTAL NANOSCIENCE
卷 2, 期 1-2, 页码 115-126出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/17458080601101176
关键词
MRI; molecular imaging; contrast agents; nanoparticles; thrombosis; mice
Nanotechnology involves working at the atomic, molecular, and macromolecular levels including imaging. Recently, four areas have emerged in cardiovascular imaging: 1. Targeted therapeutics to deliver cardioprotective drugs at the target sites they are needed; 2. Myocardial tissue engineering to replace the defective valves, damaged heart muscle, clogged blood vessels and myocardium; 3. Molecular imaging using smart'' imaging agents in targeted therapeutics and imaging; 4. Biosensors and myocardial diagnostics. Several approaches to nanoparticles i.e. dendrimers, liposomes, polymer delivery molecules, cantilevers, nanoscaffolds, nanofibers are potential candidates in cardiac visualization. The extracellular matrix plays a significant role by chemokines, cytokines and growth factors. The limitations of these emerging techniques and a new possibility of MRI visualization of mouse cardiac atheroma by superparamagnetic iron-oxide gadolinium-apoferritin (SPIOA) and myoglobin (SPIOM), for targeted functional and molecular imaging of atherosclerosis are highlighted in this paper. These emerging techniques provide an opportunity for tracking functional and structural changes in myocardium and heart tissue.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据